Brief: 4D Molecular Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing
09/08/2023 22:11
Aug 9 (Reuters) - 4D Molecular Therapeutics Inc
FDMT.O :
* 4D MOLECULAR THERAPEUTICS INC FILES FOR MIXED SHELF OF UP
TO
$300 MILLION – SEC FILING
Source text for Eikon: [http://bitly.ws/Ruaf]
Further company coverage: FDMT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings